Vor Biopharma Inc. (VOR) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 1.04B USD. 52-week range 6.50 to 33.50 USD. Trailing P/E 0.1. Data as of 2026-10-09.
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related ...